it is a new receptor drug for the treatment of alimentary dystrophy and protein-energy malnutrition (PEM)
is a new receptor product for the normalization of protein-energy malnutrition (PEM) and stimulation of the growth of muscle mass in pigs.
About
is a young but rapidly growing company that was established in 2020. Bringing our innovative products to the global market is helping the company contribute to finding solutions to some of the major livestock problems that are faced worldwide.
Company activities
The company continually develops new drug formulations for both human and veterinary medicine;
The company supplies human medical drugs across Central Asia and CIS;
The company invented a revolutionary drug formula for treatment of animal distrophia;
The company established trustful relationships with distributors across Central Asia and CIS since 2018
Core values
HONESTY AND INTEGRITY
Each employee maintains the highest ethical standards and acts to protect and uphold the regulations and procedures required to produce quality drug products.
QUALITY AND SAFETY
The company is committed to producing safe and effective products, along with providing reliable information and service to our partners. We also have a strict guideline to all our stakeholders to be sure that CSR is maintained in accordance with the corporate culture.
INNOVATION AND CONTINUOUS IMPROVEMENT
Each employee has a “can do” attitude that manifests itself by creatively turning problems into solutions. This attitude is present at all levels in our company and is applied to all aspects of our operations. Each employee promotes and supports continuous efforts that lead to improvements in our processes, products, services and workplace.
The main strategies of the company for this year
Introduction of our products to new markets.
Expansion of a number of distributors on the global market.
Enhancement of the company's footprint worldwide.
Contacts
Representative office in Uzbekistan
100031, Beshchinar st., 2, Tashkent, Uzbekistan